Full Length Research Paper
References
|
Anil Kumar V, Babu R (2013). Fecal Carriage of Extended-Spectrum β-Lactamase Producing Enterobacteriaceae. J. Med. Microbiol. Diagn. 2(3):1000e119. |
|
|
Arnaud I, Maugat S, Jarlier V, Astagneau P (2015). Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013. Eur. Surveill. 20(36):1-7. |
|
|
Baba Ahmed-Kazi Tani Z, Decré D, Genel N, Boucherit-Otmani Z, Arlet G, Drissi M (2013). Molecular and epidemiological characterization of enterobacterial multidrug- resistant strains in Tlemcen Hospital (Algeria) (2008–2010). Microbiol. Drug Resist. 19:185-190. |
|
|
Berrazeg M, Drissi M, Medjahed L, Rolain JM (2013). Hierarchical clustering as a rapid tool for surveillance of emerging antibiotic resistance phenotypes in Klebsiella pneumoniae strains. J. Med. Microbiol. 62:864-874. |
|
|
Bonnet R (2004). Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14. |
|
|
Bonnet R, Sampaio JL, Chanal C, Sirot D, De Champs C, Viallard JL, Labia R, Sirot J (2000). A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil. Antimicrob. Agents Chemother. 4(11):3061-3068. |
|
|
Bradford PA (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951. |
|
|
CASFM (2010). Antibiogram Committee of French Society for Microbiology. Communique 2010. Paris. France. View. |
|
|
Chanal C, Poupart MC, Sirot D, Labia R, Sirot J, Cluzel R (1992).Nucleotide sequences of CAZ-6, and CAZ-7 beta-lactamase genes. Antimicrob. Agents Chemother. 36:1817-1820. |
|
|
Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Cantón R, Nordmann P (2008). Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200. |
|
|
Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D (2013). Urinary tract infections caused by community-acquired extended-spectrum beta-lactamase producing and nonproducing bacteria: a comparative study. J. Pediatr. 163:1417-1421. |
|
|
De Champs C, Chanal C, Sirot D, Baraduc R, Romaszko JP, Bonnet R, Plaidy A, Boyer M, Carroy E, Gbadamassi MC, Laluque S (2004). Frequency and diversity of class A extended-spectrum β-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. J. Antimicrob. Chemother. 54(3):634-639. |
|
|
Dumarche P, De Champs C, Sirot D, Chanal C, Bonnet R, Sirot J (2002). TEM derivative-producing Enterobacter aerogenes strains: dissemination of a prevalent clone. Antimicrob. Agents Chemother. 46:1128-1131. |
|
|
El-Khizzi NA, Bakheshwain SM (2006). Prevalence of extended spectrum β-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital. Saudi Med. J. 27:37-40. |
|
|
Fernandez-Reyes M, Vicente D, Gomariz M, Esnal O, Landa J, Onate E, Pérez-Teallero E (2014). High rate of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in healthy children in Gipuzkoa, northern Spain. Antimicrob. Agents Chemother. 58:1822-1824. |
|
|
Gharout-Sait A, Touati A, Benallaoua S, Guillard T, Brasme L, Madoux J, De Champs C (2012). CTX-M from community-acquired urinary tract infections in Algeria. Afr. J. Microbiol. Res. 6:5306-5313. |
|
|
Giriyapur RS, Nandihal NW, Krishna BVS, Patil AB, Chandrasekhar MR (2011). Comparison of Disc Diffusion Methods for the Detection of Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae. J. Lab. Physicians. 3(1):33-36. |
|
|
Heritage J, Ransomeb N, Chambersa PA, Wilcox MH (2001). A comparison of culture and PCR to determine the prevalence of ampicillin-resistant bacteria in the faecal flora of general practice patients. J. Antimicrob. Chemother. 48(2):287-289. |
|
|
Iabadene H, Messai Y, Ammari H, Ramdani-Bouguessa N, Lounes S, Bakour R, Arlet G (2008). Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria. J. Antimicrob Chemother. 62:133-136. |
|
|
Jarlier V, Nicolas MH, Fournier G, Philippon A (1988). Extended-broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878. |
|
|
Jones-Dias D, Manageiro V, Ferreira E, Louro D, Antibiotic Resistance Surveillance Program in Portugal (ARSIP) Participants, and Manuela Canica (2014). Diversity of Extended-Spectrum and Plasmid-Mediated AmpC β-Lactamases in Enterobacteriaceae Isolates from Portuguese Health Care Facilities. J. Microbiol. 52(6):496-503. |
|
|
Kaarme J, Molin Y, Olsen B, Melhus A (2013). Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in healthy Swedish preschool children. Acta Paediatr. 102:655-660. |
|
|
Kado CI, Liu ST (1981). Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1365-1373. |
|
|
Karisik E, Ellington MJ, Pike R, Warren RE, Livermore DM, Woodford N (2006). Molecular characterization of plasmids encoding CTX-M-15 β-lactamases from Escherichia coli strains in the United Kingdom. J. Antimicrob. Chemother. 58:665-668. |
|
|
Kasap M, Fashae K, Torol S, Kolayli F, Budak F, Vahaboglu H (2010). Characterization of ESBL (SHV-12) producing clinical isolate of Enterobacter aerogenes from atertiary care hospital in Nigeria. Ann. Clin. Microbiol. Antimicrob. 9(1):1. |
|
|
Kermas R, Touati A, Brasme L, Le Magrex-Debar E, Mehrane S, Weill FX, De Champs C (2012). Characterization of extended-spectrum β-lactamase-producing Salmonella enterica serotype Brunei and Heidelberg at the Hussein Dey hospital in Algiers (Algeria). Foodborne Pathog. Dis. 9:803-808. |
|
|
Khan AA, Mc Carthy S, Wang RF, Cerniglia CE (2002). Characterization of United States outbreak isolates of Vibrio parahaemolyticus using enterobacterial repetitive intergenic consensus (ERIC) PCR and development of a rapid PCR method for detection of O3: K6 isolates. FEMS. Microbiol. Lett. 206:209-214. |
|
|
Kim J, Kwon Y, Pai H, Kim JW, Cho DT (1998). Survey of Klebsiella pneumonia strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J. Clin. Microbiol. 36:1446-1449. |
|
|
Lagha N, Abdelouahid DE, Hassaine H, Robin F, Bonnet R (2014). First characterization of CTX-M-15 and DHA-1 β-lactamases among clinical isolates of Klebsiella pneumoniae in Laghouat Hospital, Algeria. Afr. J. Microbiol. Res. 8(11):1221-1227. |
|
|
Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, Poirel L, Woodford N (2007). CTX-M: changingthe face of ESBLs in Europe. J. Antimicrob. Chemother. 59(2):165-174. |
|
|
Lukac PJ, Bonomo RA, Logan LK (2015). Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Children: Old Foe, Emerging Threat. Clin. Infect. Dis. Adv. 60(9):1389-1397. |
|
|
Marco MD, Fabio A, Lucia P, Gian MR (2013). CTX-M-type β-lactamases: A successful story of antibiotic resistance. Int. J. Med. Microbiol. 303(6):305-317. |
|
|
Martinez-Pastor JC, Vilchez C, Pitart C (2010). Antibiotic resistance in orthopaedic surgery: acute knee prosthetic joint infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae. Eur. J. Clin. Microbiol. Infect. Dis. 29:1039-1041. |
|
|
Messai Y, Iabadene H, Benhassine T, Alouache S, Tazir M, Gautier V, Arlet G, Bakour R (2008). Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiellapneumoniae in Algiers hospitals (Algeria). Pathol. Biol. 56(5):319-325. |
|
|
Morrissey I, Hackel M, Badal R, Bouchillon S, Hawser S, Biedenbach D (2013). A review of ten years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011. Pharmaceuticals 6:1335-1346. |
|
|
Mulisa G, Selassie LG, Jarso G, Shiferew T, Zewdu A, Abebe W, Belachew F, Sewunet T (2016). Prevalence of Extended Spectrum Beta-lactamase Producing Enterobacteriaceae: A Cross Sectional Study at Adama Hospital, Adama, Ethiopia. J. Emerg. Infect. Dis. 1(1):2-6. |
|
|
Nedjai S, Barguigua A, Djahmi N, Jamali L, Zerouali K, Dekhil M, Timinouni M (2012). Prevalence and characterization of extended spectrum beta-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria. Med. Mal. Infect. 42:20-29. |
|
|
Oteo J, Cercenado E, Vindel A, Bautista V, Fernandez-Romero S, Saéz D, Padilla B, Zamora E, Campos J (2013). Outbreak of multidrug-resistant CTX-M-15-producing Enterobacter cloacae in a neonatal intensive care unit. J. Med. Microbiol. 62:571-575. |
|
|
Paterson DL (2000). Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs). Clin. Microbiol. Infect. 6:460-463. |
|
|
Pitout JD (2010). Infections with extended-spectrum β-lactamase producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70:313-333. |
|
|
Poirel L, Decousser JW, Nordmann P (2003). Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M β-lactamase gene. Antimicrob. Agents Chemother. 47:2938-2945. |
|
|
Rakotonirina HC, Garin B, Randrianirina F, Richard V, Talarmin A, Arlet G (2013). Molecular characterization of multidrug-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar. BMC Microbiol. 13:1-10. |
|
|
Ramdani-Bouguessa N, Mendonca N, Leitao J, Ferreira E, Tazir M, Canica M (2006). CTX-M-3 and CTX-M-15 extended-spectrum β-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria. J. Clin. Microbiol. 44:4584-4596. |
|
|
Rasheed JK, Jay C, Metchock B, Berkowitz F, Weigel L, Crellin J, Steward C, Hill B, Medeiros AA, Tenover FC (1997). Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coliduring multiple episodes of bacteremia. Antimicrob. Agents Chemother. 41:647-653. |
|
|
Réjiba S, Mercuri PS, Power P, Kechrid A (2011). Emergence and dominance of CTX-M-15 extended-spectrum β-lactamase among Escherichia coli isolates from children. Microb. Drug Resist. 17:135-140. |
|
|
Robin F, Delmas J, Chanal C, Sirot D, Sirot J, Bonnet R (2005). TEM-109 (CMT-5), a Natural Complex Mutant of TEM-1 β-Lactamase Combining the Amino Acid Substitutions of TEM-6 and TEM-33 (IRT-5). Antimicrob. Agents Chemother. 49(49):4443-4445. |
|
|
Rodriguez-Villalobos H, Struelens MJ (2006). Extended-spectrum β-lactamases mediated bacterial resistance: Implications for the intensivist. Rev Réanimation. 15(3):205-213. |
|
|
Rossolini GM, D'Andrea MM, Mugnaioli C (2008). The spread of CTX-M type extended-spectrum β-lactamases. Clin. Microbiol. Infect. Rev. 14(1):33-41. |
|
|
Sambrook J, Tritsch EF, Maniatis T (1989). Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. 2nd ed. 1: 1659. |
|
|
Sanger F, Nicklen S, Coulson AR (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467. |
|
|
Shahid M, Sobia F, Singh A, Malik A, Khan HM, Jonas D, Hawkez PM (2009). Beta-lactams and beta-lactamase-inhibitors in current or potential clinical practice: A comprehensive update. Crit. Rev. Microbiol. 35(2):81-108. |
|
|
Soraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA (2013). Risk Factors for Community-Acquired Urinary Tract Infections Caused by ESBL Producing Enterobacteriaceae –A Case–Control Study in a Low Prevalence Country. PLoS One 8(7):e69581. |
|
|
Toubiana J, Timsit S, Ferroni A, Grasseau M, Nassif X, Lortholary O, MD, Zahar JR, MD, Chalumeau M (2016). Community-Onset Extended-Spectrum β-Lactamase- Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France. Med. J. 95(12):e3163. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
